MouseMine: Keyword Search

Publication

First Author:	Wen D
Year:	2023
Journal:	Front Cardiovasc Med
Title:	Mechanical injury accentuates lipid deposition in ApoE(-/-) mice and advance aortic valve stenosis: A novel modified aortic valve stenosis model.
Volume:	10

Pages:	1119746

•

Protein

P51908

Organism:	Mus musculus/domesticus
Length:	229
Fragment?:	false

•

Protein

Q3U9G8

Organism:	Mus musculus/domesticus
Length:	229
Fragment?:	false

•

Protein

Q3TLN2

Organism:	Mus musculus/domesticus
Length:	229
Fragment?:	false

•

Publication

11134005 | J:320144

First Author:	Blanc V
Year:	2001
Journal:	J Biol Chem
Title:	Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing.
Volume:	276
Issue:	13
Pages:	10272-83

•

Publication

30309881 | J:277521

First Author:	Blanc V
Year:	2019
Journal:	RNA
Title:	Apobec1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liver.
Volume:	25
Issue:	1
Pages:	70-81

•

Publication

29976766 | J:285156

First Author:	Wilson PG
Year:	2018
Journal:	Arterioscler Thromb Vasc Biol
Title:	Serum Amyloid A Is an Exchangeable Apolipoprotein.
Volume:	38
Issue:	8
Pages:	1890-1900

•

Publication

24030551 | J:222215

First Author:	VerHague MA
Year:	2013
Journal:	Arterioscler Thromb Vasc Biol
Title:	Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion.
Volume:	33
Issue:	11
Pages:	2501-8

•

Publication

23814116 | J:222231

First Author:	Bi X
Year:	2013
Journal:	Arterioscler Thromb Vasc Biol
Title:	Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.
Volume:	33
Issue:	10
Pages:	2288-96

•

Publication

26980204 | J:252584

First Author:	Tavori H
Year:	2016
Journal:	Cardiovasc Res
Title:	Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.
Volume:	110
Issue:	2
Pages:	268-78

•

Publication

16928680 | J:117282

First Author:	Joyce CW
Year:	2006
Journal:	J Biol Chem
Title:	ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis.
Volume:	281
Issue:	44
Pages:	33053-65

•

Publication

33057430 | J:296721

First Author:	Vishnyakova TG
Year:	2020
Journal:	PLoS One
Title:	SR-BI mediates neutral lipid sorting from LDL to lipid droplets and facilitates their formation.
Volume:	15
Issue:	10
Pages:	e0240659

•

Publication

10585451 | J:58895

First Author:	Mensenkamp AR
Year:	1999
Journal:	J Biol Chem
Title:	Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver.
Volume:	274
Issue:	50
Pages:	35711-8

•

Publication

15304509 | J:94495

First Author:	González-Navarro H
Year:	2004
Journal:	J Biol Chem
Title:	The ligand-binding function of hepatic lipase modulates the development of atherosclerosis in transgenic mice.
Volume:	279
Issue:	44
Pages:	45312-21

•

Publication

9442022 | J:229080

First Author:	Dichek HL
Year:	1998
Journal:	J Biol Chem
Title:	Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake.
Volume:	273
Issue:	4
Pages:	1896-903

•

Publication

21423135 | J:172001

First Author:	Kanuri G
Year:	2011
Journal:	Lab Invest
Title:	Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells.
Volume:	91
Issue:	6
Pages:	885-95

•

Publication

22121032 | J:210793

First Author:	Khatun I
Year:	2012
Journal:	Hepatology
Title:	Phospholipid transfer activity of microsomal triglyceride transfer protein produces apolipoprotein B and reduces hepatosteatosis while maintaining low plasma lipids in mice.
Volume:	55
Issue:	5
Pages:	1356-68

•

Publication

35204234 | J:324741

First Author:	Behlen JC
Year:	2022
Journal:	Antioxidants (Basel)
Title:	NRF2-Dependent Placental Effects Vary by Sex and Dose following Gestational Exposure to Ultrafine Particles.
Volume:	11
Issue:	2

•

Publication

22238606 | J:184330

First Author:	Laatsch A
Year:	2012
Journal:	PLoS One
Title:	Low density lipoprotein receptor-related protein 1 dependent endosomal trapping and recycling of apolipoprotein E.
Volume:	7
Issue:	1
Pages:	e29385

•

Publication

11389690 | J:70157

First Author:	Kendrick JS
Year:	2001
Journal:	Biochem J
Title:	Superior role of apolipoprotein B48 over apolipoprotein B100 in chylomicron assembly and fat absorption: an investigation of apobec-1 knock-out and wild-type mice.
Volume:	356
Issue:	Pt 3
Pages:	821-7

•

Publication

10946021 | J:64027

First Author:	Escolà-Gil JC
Year:	2000
Journal:	J Lipid Res
Title:	Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
Volume:	41
Issue:	8
Pages:	1328-38

•

Publication

8176896 | J:18160

First Author:	Kitagawa K
Year:	1994
Journal:	Lab Invest
Title:	Age-associated decreases in the messenger ribonucleic acid level and the rate of synthesis of apolipoprotein A-II in murine senile amyloidosis.
Volume:	70
Issue:	4
Pages:	565-71

•

Publication

7626051 | J:28613

First Author:	Srivastava RA
Year:	1995
Journal:	Biochem Biophys Res Commun
Title:	Increased apoB100 mRNA in inbred strains of mice by estrogen is caused by decreased RNA editing protein mRNA.
Volume:	212
Issue:	2
Pages:	381-7

•

Publication

8910571 | J:36752

First Author:	Huang Y
Year:	1996
Journal:	J Biol Chem
Title:	Hypolipidemic and hyperlipidemic phenotypes in transgenic mice expressing human apolipoprotein E2.
Volume:	271
Issue:	46
Pages:	29146-51

•

Publication

10064736 | J:53382

First Author:	Grunwald KA
Year:	1999
Journal:	J Lipid Res
Title:	Identification of a novel Arg-->Cys mutation in the LDL receptor that contributes to spontaneous hypercholesterolemia in pigs.
Volume:	40
Issue:	3
Pages:	475-85

•

Publication

10373583 | J:56348

First Author:	Fujino T
Year:	1999
Journal:	Nucleic Acids Res
Title:	C-->U editing of apolipoprotein B mRNA in marsupials: identification and characterisation of APOBEC-1 from the American opossum Monodelphus domestica.
Volume:	27
Issue:	13
Pages:	2662-71

•

Publication

14559896 | J:94506

First Author:	Lau PP
Year:	2003
Journal:	J Biol Chem
Title:	Involvement of a chaperone regulator, Bcl2-associated athanogene-4, in apolipoprotein B mRNA editing.
Volume:	278
Issue:	52
Pages:	52988-96

•

Publication

15388641 | J:102274

First Author:	Ribas V
Year:	2004
Journal:	Circ Res
Title:	Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Volume:	95
Issue:	8
Pages:	789-97

•

Publication

25353171 | J:223540

First Author:	Noordmans GA
Year:	2014
Journal:	PLoS One
Title:	Genetic analysis of intracapillary glomerular lipoprotein deposits in aging mice.
Volume:	9
Issue:	10
Pages:	e111308

•

Publication

25548917 | J:225372

First Author:	Ali K
Year:	2014
Journal:	PLoS One
Title:	A Western-fed diet increases plasma HDL and LDL-cholesterol levels in apoD-/- mice.
Volume:	9
Issue:	12
Pages:	e115744

•

Publication

29107995 | J:252884

First Author:	Uemura Y
Year:	2017
Journal:	PLoS One
Title:	The intratracheal administration of locked nucleic acid containing antisense oligonucleotides induced gene silencing and an immune-stimulatory effect in the murine lung.
Volume:	12
Issue:	11
Pages:	e0187286

•

Publication

28131846 | J:255442

First Author:	Gaglione R
Year:	2017
Journal:	Biochem Pharmacol
Title:	Novel human bioactive peptides identified in Apolipoprotein B: Evaluation of their therapeutic potential.
Volume:	130

Pages:	34-50

•

Publication

35097028 | J:319714

First Author:	Nettersheim FS
Year:	2021
Journal:	Front Cardiovasc Med
Title:	Autoimmune Regulator (AIRE) Deficiency Does Not Affect Atherosclerosis and CD4 T Cell Immune Tolerance to Apolipoprotein B.
Volume:	8

Pages:	812769

•

Publication

16601207 | -

First Author:	Moraes KC
Year:	2006
Journal:	RNA
Title:	CUG-BP binds to RNA substrates and recruits PARN deadenylase.
Volume:	12
Issue:	6
Pages:	1084-91

•

Publication

8948631 | -

First Author:	Timchenko LT
Year:	1996
Journal:	Nucleic Acids Res
Title:	Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy.
Volume:	24
Issue:	22
Pages:	4407-14

•

Publication

16862542 | -

First Author:	Leroy O
Year:	2006
Journal:	J Neurosci Res
Title:	ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I.
Volume:	84
Issue:	4
Pages:	852-9

•

Publication

11124939 | -

First Author:	Timchenko NA
Year:	2001
Journal:	J Biol Chem
Title:	RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1.
Volume:	276
Issue:	11
Pages:	7820-6

•

Publication

18267972 | -

First Author:	Graindorge A
Year:	2008
Journal:	Nucleic Acids Res
Title:	Identification of CUG-BP1/EDEN-BP target mRNAs in Xenopus tropicalis.
Volume:	36
Issue:	6
Pages:	1861-70

•

Publication

16836486 | -

First Author:	Cosson B
Year:	2006
Journal:	Biol Cell
Title:	Oligomerization of EDEN-BP is required for specific mRNA deadenylation and binding.
Volume:	98
Issue:	11
Pages:	653-65

•

Publication

11577082 | -

First Author:	Anant S
Year:	2001
Journal:	J Biol Chem
Title:	Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.
Volume:	276
Issue:	50
Pages:	47338-51

•

Publication

15226369 | -

First Author:	Ladd AN
Year:	2004
Journal:	J Cell Sci
Title:	Multiple domains control the subcellular localization and activity of ETR-3, a regulator of nuclear and cytoplasmic RNA processing events.
Volume:	117
Issue:	Pt 16
Pages:	3519-29

•

Protein

Q6P6J0

Organism:	Mus musculus/domesticus
Length:	191
Fragment?:	false

•

Protein

Q9WVE0

Organism:	Mus musculus/domesticus
Length:	198
Fragment?:	false

•

Protein

Q99J72

Organism:	Mus musculus/domesticus
Length:	440
Fragment?:	false

•

Protein

E2D876

Organism:	Mus musculus/domesticus
Length:	180
Fragment?:	true

•

Protein

E2D875

Organism:	Mus musculus/domesticus
Length:	180
Fragment?:	true

•

Protein

Q3U5C5

Organism:	Mus musculus/domesticus
Length:	396
Fragment?:	false

•

Protein

Q8N155

Organism:	Mus musculus/domesticus
Length:	198
Fragment?:	true

•

Protein

B9ZZS3

Organism:	Mus musculus/domesticus
Length:	396
Fragment?:	false

•

Protein

E2D872

Organism:	Mus musculus/domesticus
Length:	180
Fragment?:	true

•

Protein

Q8NHG5

Organism:	Mus musculus/domesticus
Length:	198
Fragment?:	true

•

Protein

Q8NHF8

Organism:	Mus musculus/domesticus
Length:	198
Fragment?:	true

•

Protein

B5T0J0

Organism:	Mus musculus/domesticus
Length:	373
Fragment?:	false

•

Protein

B5T0I9

Organism:	Mus musculus/domesticus
Length:	396
Fragment?:	false

•

Protein

Q546Y8

Organism:	Mus musculus/domesticus
Length:	198
Fragment?:	true

•

Protein

E2D6P3

Organism:	Mus musculus/domesticus
Length:	392
Fragment?:	true

•

Protein

Q8NHG6

Organism:	Mus musculus/domesticus
Length:	198
Fragment?:	false

•

Protein

E2D866

Organism:	Mus musculus/domesticus
Length:	180
Fragment?:	true

•

Protein

Q8NHF9

Organism:	Mus musculus/domesticus
Length:	198
Fragment?:	true

•

Protein

Q8NHG3

Organism:	Mus musculus/domesticus
Length:	198
Fragment?:	true

•

Protein

E2D881

Organism:	Mus musculus/domesticus
Length:	180
Fragment?:	true

•

Protein

A0A2R8VKS7

Organism:	Mus musculus/domesticus
Length:	97
Fragment?:	true

•

Protein

Q8NHG2

Organism:	Mus musculus/domesticus
Length:	198
Fragment?:	true

•

Protein

A0A0N4SVL6

Organism:	Mus musculus/domesticus
Length:	113
Fragment?:	true

•

Protein

Q8NHF7

Organism:	Mus musculus/domesticus
Length:	191
Fragment?:	true

•

Protein

E2D6P1

Organism:	Mus musculus/domesticus
Length:	421
Fragment?:	true

•

Protein

B5T0I8

Organism:	Mus musculus/domesticus
Length:	373
Fragment?:	false

•

Protein

Q8NHG0

Organism:	Mus musculus/domesticus
Length:	198
Fragment?:	true

•

Protein

Q8NHG4

Organism:	Mus musculus/domesticus
Length:	198
Fragment?:	true

•

Protein

B5T0I7

Organism:	Mus musculus/domesticus
Length:	429
Fragment?:	false

•

Protein

E9QMH1

Organism:	Mus musculus/domesticus
Length:	429
Fragment?:	false

•

Protein

A0A0N4SW85

Organism:	Mus musculus/domesticus
Length:	121
Fragment?:	true

•

Protein

E2D6P2

Organism:	Mus musculus/domesticus
Length:	372
Fragment?:	true

•

Protein

E2D865

Organism:	Mus musculus/domesticus
Length:	180
Fragment?:	true

•

Protein

Q8NHG1

Organism:	Mus musculus/domesticus
Length:	198
Fragment?:	true

•

Protein

B9ZZS2

Organism:	Mus musculus/domesticus
Length:	429
Fragment?:	false

•

Protein

Q3TI69

Organism:	Mus musculus/domesticus
Length:	297
Fragment?:	false

•

Protein

E2D874

Organism:	Mus musculus/domesticus
Length:	180
Fragment?:	true

•

Publication

1567863 | -

First Author:	Yang C
Year:	1992
Journal:	Biochemistry
Title:	Cloning and nucleotide sequence of the Escherichia coli cytidine deaminase (ccd) gene.
Volume:	31
Issue:	17
Pages:	4168-74

•

Protein Domain

IPR034198 | CELF1/2_RRM2

Type:

Domain

Description:

The human CELF family has six members, which can be divided into two subfamilies based on their phylogeny: CELF1-2 and CELF3-6. This entry represents the RNA recognition motif 2 (RRM2) of CELF-1 and CELF-2 protein. CELF-1 and CELF-2 belong to the CELF (CUGBP and ETR-3 Like Factor)/Bruno-like protein family, whose members play important roles in the regulation of alternative splicing and translation. CELF-1 and CELF-2 share sequence similarity to the Drosophila Bruno protein and binds to the Bruno response elements (cis-acting sequences in the 3'-untranslated region (UTR) ofoskar mRNA) [].The human CELF-1 (also known as CUG-BP or BRUNOL-2) binds to RNA substrates and recruits PARN deadenylase []. It preferentially targets UGU-rich mRNA elements []. CELF-1 has been implicated in onset of type 1 myotonic dystrophy (DM1), a neuromuscular disease associated with an unstable CUG triplet expansion in the 3'-UTR (3'-untranslated region) of the DMPK (myotonic dystrophy protein kinase) gene [, ]. CELF-1 contain three highly conserved RNA recognition motifs (RRMs): two consecutive RRMs (RRM1 and RRM2) situated in the N-terminal region followed by a linker region and the third RRM (RRM3) close to the C terminus of the protein. The Xenopus homologue of CELF-1 is EDEN-BP (embryo deadenylation element-binding protein), which mediates sequence-specific deadenylation of Eg5 mRNA. It binds specifically to the EDEN motif in the 3'-untranslated regions of maternal mRNAs and targets these mRNAs for deadenylation and translational repression []. The two N-terminal RRMs of EDEN-BP are necessary for the interaction with EDEN as well as a part of the linker region (between RRM2 and RRM3). Oligomerization of EDEN-BP is required for specific mRNA deadenylation and binding []. CELF-2 (also known as CUGBP2 or ETR-3) shares high sequence identity with CELF-1, but shows different binding specificity; it binds preferentially to sequences with UG repeats and UGUU motifs. It also binds to the 3'-UTR of cyclooxygenase-2 messages, affecting both translation and mRNA stability, and binds to apoB mRNA, regulating its C to U editing []. CELF-2 also contains three highly conserved RRMs. It binds to RNA via the first two RRMs, which are also important for localization in the cytoplasm. The splicing activation or repression activity of CELF-2 on some specific substrates is mediated by RRM1/RRM2. Both, RRM1 and RRM2 of CELF-2, can activate cardiac troponin T (cTNT) exon 5 inclusion. In addition, CELF-2 possesses a typical arginine and lysine-rich nuclear localization signal (NLS) in the C terminus, within RRM3 [].

•

Protein Domain

IPR034199 | CELF1/2_RRM3

Type:

Domain

Description:

The human CELF family has six members, which can be divided into two subfamilies based on their phylogeny: CELF1-2 and CELF3-6. This entry represents the RNA recognition motif 3 (RRM3) of CELF-1 andCELF-2 protein. CELF-1 and CELF-2 belong to the CELF (CUGBP and ETR-3 Like Factor)/Bruno-like protein family, whose members play important roles in the regulation of alternative splicing and translation. CELF-1 and CELF-2 share sequence similarity to the Drosophila Bruno protein and binds to the Bruno response elements (cis-acting sequences in the 3'-untranslated region (UTR) ofoskar mRNA) [].The human CELF-1 (also known as CUG-BP or BRUNOL-2) binds to RNA substrates and recruits PARN deadenylase []. It preferentially targets UGU-rich mRNA elements []. CELF-1 has been implicated in onset of type 1 myotonic dystrophy (DM1), a neuromuscular disease associated with an unstable CUG triplet expansion in the 3'-UTR (3'-untranslated region) of the DMPK (myotonic dystrophy protein kinase) gene [, ]. CELF-1 contain three highly conserved RNA recognition motifs (RRMs): two consecutive RRMs (RRM1 and RRM2) situated in the N-terminal region followed by a linker region and the third RRM (RRM3) close to the C terminus of the protein. The Xenopus homologue of CELF-1 is EDEN-BP (embryo deadenylation element-binding protein), which mediates sequence-specific deadenylation of Eg5 mRNA. It binds specifically to the EDEN motif in the 3'-untranslated regions of maternal mRNAs and targets these mRNAs for deadenylation and translational repression []. The two N-terminal RRMs of EDEN-BP are necessary for the interaction with EDEN as well as a part of the linker region (between RRM2 and RRM3). Oligomerization of EDEN-BP is required for specific mRNA deadenylation and binding []. CELF-2 (also known as CUGBP2 or ETR-3) shares high sequenceidentity with CELF-1, but shows different binding specificity; it binds preferentially to sequences with UG repeats and UGUU motifs. It also binds to the 3'-UTR of cyclooxygenase-2 messages, affecting both translation and mRNA stability, and binds to apoB mRNA, regulating its C to U editing []. CELF-2 also contains three highly conserved RRMs. It binds to RNA via the first two RRMs, which are also important for localization in the cytoplasm. The splicing activation or repression activity of CELF-2 on some specific substrates is mediated by RRM1/RRM2. Both, RRM1 and RRM2 of CELF-2, can activate cardiac troponin T (cTNT) exon 5 inclusion. In addition, CELF-2 possesses a typical arginine and lysine-rich nuclear localization signal (NLS) in the C terminus, within RRM3 [].

•

Publication

20042190 | J:329225

First Author:	Rosenblat M
Year:	2010
Journal:	Atherosclerosis
Title:	Increased macrophage cholesterol biosynthesis and decreased cellular paraoxonase 2 (PON2) expression in Delta6-desaturase knockout (6-DS KO) mice: beneficial effects of arachidonic acid.
Volume:	210
Issue:	2
Pages:	414-21

•

Publication

23297223 | J:193711

First Author:	Olzmann JA
Year:	2013
Journal:	Proc Natl Acad Sci U S A
Title:	Spatial regulation of UBXD8 and p97/VCP controls ATGL-mediated lipid droplet turnover.
Volume:	110
Issue:	4
Pages:	1345-50

•

Publication

7768898 | J:25752

First Author:	Nakamuta M
Year:	1995
Journal:	J Biol Chem
Title:	Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases.
Volume:	270
Issue:	22
Pages:	13042-56

•

Publication

30849508 | J:279783

First Author:	Spencer B
Year:	2019
Journal:	Neurobiol Dis
Title:	Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease.
Volume:	127

Pages:	163-177

•

Publication

25344410 | J:229082

First Author:	Smallwood TL
Year:	2014
Journal:	G3 (Bethesda)
Title:	High-resolution genetic mapping in the diversity outbred mouse population identifies Apobec1 as a candidate gene for atherosclerosis.
Volume:	4
Issue:	12
Pages:	2353-63

•

Publication

10574922 | J:58708

First Author:	Hersberger M
Year:	1999
Journal:	J Biol Chem
Title:	Phylogenetic analysis of the apolipoprotein B mRNA-editing region. Evidence for a secondary structure between the mooring sequence and the 3' efficiency element.
Volume:	274
Issue:	49
Pages:	34590-7

•

Publication

1683257 | J:2839

First Author:	Srivastava RA
Year:	1991
Journal:	Biochim Biophys Acta
Title:	In vivo regulation of low-density lipoprotein receptor and apolipoprotein B gene expressions by dietary fat and cholesterol in inbred strains of mice.
Volume:	1086
Issue:	1
Pages:	29-43

•

Publication

8999814 | J:38456

First Author:	Oka K
Year:	1997
Journal:	J Biol Chem
Title:	Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
Volume:	272
Issue:	3
Pages:	1456-60

•

Publication

9278267 | J:43121

First Author:	Srivastava RA
Year:	1997
Journal:	Mol Cell Biochem
Title:	Regulation of lipoprotein metabolism by estrogen in inbred strains of mice occurs primarily by posttranscriptional mechanisms.
Volume:	173
Issue:	1-2
Pages:	161-8

•

Publication

9407129 | J:44860

First Author:	Srivastava RA
Year:	1997
Journal:	J Biol Chem
Title:	Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway.
Volume:	272
Issue:	52
Pages:	33360-6

•

Publication

10893231 | J:74955

First Author:	Good PJ
Year:	2000
Journal:	J Biol Chem
Title:	A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator.
Volume:	275
Issue:	37
Pages:	28583-92

•

Protein

P28659

Organism:	Mus musculus/domesticus
Length:	486
Fragment?:	false

•

Protein

A0A0R4J0T5

Organism:	Mus musculus/domesticus
Length:	487
Fragment?:	false

•

Publication

36672207 | J:336232

First Author:	Hagmann H
Year:	2023
Journal:	Cells
Title:	Capsazepine (CPZ) Inhibits TRPC6 Conductance and Is Protective in Adriamycin-Induced Nephropathy and Diabetic Glomerulopathy.
Volume:	12
Issue:	2

•

Publication

29899553 | J:266125

First Author:	Yang L
Year:	2018
Journal:	Nat Commun
Title:	UBXN3B positively regulates STING-mediated antiviral immune responses.
Volume:	9
Issue:	1
Pages:	2329

•

Protein

P56389

Organism:	Mus musculus/domesticus
Length:	146
Fragment?:	false

•

Protein

Q8BMD5

Organism:	Mus musculus/domesticus
Length:	523
Fragment?:	false

•

Protein

O35490

Organism:	Mus musculus/domesticus
Length:	407
Fragment?:	false

•

Protein

Q91WS4

Organism:	Mus musculus/domesticus
Length:	363
Fragment?:	false

•

Your name:
Your email address:
Subject:
Message:	---- Current page: ---- /mousemine/keywordSearchResults.do;jsessionid=4A28B5F7ABB896EBBD33CCA7332A25CE?searchTerm=Apob&searchBag=&searchOffset=900

MouseMine

Search our database by keyword

Examples

Search results 901 to 1000 out of 1066 for Apob

Categories

Hits by Pathway

Hits by Strain

Hits by Category